1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Caxton Corp Buys Sierra Oncology Inc, Kala Pharmaceuticals Inc, Crescent Capital BDC Inc, Sells Alcentra Capital Corp, SPDR S&P 500, Cardlytics Inc

Princeton, NJ, based Investment company Caxton Corp (Current Portfolio) buys Sierra Oncology Inc, Kala Pharmaceuticals Inc, Crescent Capital BDC Inc, CTI BioPharma Corp, FS KKR Capital Corp, sells Alcentra Capital Corp, SPDR S&P 500, Cardlytics Inc, Assembly Biosciences Inc, Arqule Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Caxton Corp. As of 2020Q1, Caxton Corp owns 15 stocks with a total value of $78 million. These are the details of the buys and sells.

For the details of CAXTON CORP's stock buys and sells, go to https://www.gurufocus.com/guru/caxton+corp/current-portfolio/portfolio

These are the top 5 holdings of CAXTON CORP
  1. Molecular Templates Inc (MTEM) - 2,107,991 shares, 35.77% of the total portfolio. Shares added by 0.72%
  2. Kala Pharmaceuticals Inc (KALA) - 1,836,313 shares, 20.61% of the total portfolio. Shares added by 23.80%
  3. Strongbridge Biopharma PLC (SBBP) - 6,612,065 shares, 15.96% of the total portfolio.
  4. Sierra Oncology Inc (SRRA) - 643,959 shares, 8.08% of the total portfolio. New Position
  5. SCYNEXIS Inc (SCYX) - 7,936,111 shares, 7.91% of the total portfolio.
New Purchase: Sierra Oncology Inc (SRRA)

Caxton Corp initiated holding in Sierra Oncology Inc. The purchase prices were between $9.04 and $19.55, with an estimated average price of $13.19. The stock is now traded at around $11.66. The impact to a portfolio due to this purchase was 8.08%. The holding were 643,959 shares as of .

New Purchase: Crescent Capital BDC Inc (CCAP)

Caxton Corp initiated holding in Crescent Capital BDC Inc. The purchase prices were between $6.21 and $17.1, with an estimated average price of $13.88. The stock is now traded at around $10.69. The impact to a portfolio due to this purchase was 0.42%. The holding were 34,405 shares as of .

Added: Kala Pharmaceuticals Inc (KALA)

Caxton Corp added to a holding in Kala Pharmaceuticals Inc by 23.80%. The purchase prices were between $3.69 and $8.79, with an estimated average price of $6.36. The stock is now traded at around $12.17. The impact to a portfolio due to this purchase was 3.96%. The holding were 1,836,313 shares as of .

Added: CTI BioPharma Corp (CTIC)

Caxton Corp added to a holding in CTI BioPharma Corp by 89.40%. The purchase prices were between $0.69 and $1.58, with an estimated average price of $1.16. The stock is now traded at around $1.05. The impact to a portfolio due to this purchase was 0.34%. The holding were 616,695 shares as of .

Added: FS KKR Capital Corp (FSK)

Caxton Corp added to a holding in FS KKR Capital Corp by 52.55%. The purchase prices were between $2.36 and $6.31, with an estimated average price of $5.39. The stock is now traded at around $3.16. The impact to a portfolio due to this purchase was 0.22%. The holding were 170,332 shares as of .

Added: Eiger BioPharmaceuticals Inc (EIGR)

Caxton Corp added to a holding in Eiger BioPharmaceuticals Inc by 31.44%. The purchase prices were between $4.91 and $14.9, with an estimated average price of $10.76. The stock is now traded at around $11.99. The impact to a portfolio due to this purchase was 0.17%. The holding were 81,617 shares as of .

Sold Out: Alcentra Capital Corp (ABDC)

Caxton Corp sold out a holding in Alcentra Capital Corp. The sale prices were between $8.9 and $9.48, with an estimated average price of $9.19.

Sold Out: SPDR S&P 500 (SPY)

Caxton Corp sold out a holding in SPDR S&P 500. The sale prices were between $222.95 and $338.34, with an estimated average price of $305.03.

Sold Out: Cardlytics Inc (CDLX)

Caxton Corp sold out a holding in Cardlytics Inc. The sale prices were between $29.49 and $102.99, with an estimated average price of $71.32.

Sold Out: Assembly Biosciences Inc (ASMB)

Caxton Corp sold out a holding in Assembly Biosciences Inc. The sale prices were between $10.27 and $21.23, with an estimated average price of $17.94.

Sold Out: Charter Communications Inc (CHTR)

Caxton Corp sold out a holding in Charter Communications Inc. The sale prices were between $371.7 and $542.46, with an estimated average price of $489.92.

Sold Out: Arqule Inc (ARQL)

Caxton Corp sold out a holding in Arqule Inc. The sale prices were between $19.96 and $20.04, with an estimated average price of $20.



Here is the complete portfolio of CAXTON CORP. Also check out:

1. CAXTON CORP's Undervalued Stocks
2. CAXTON CORP's Top Growth Companies, and
3. CAXTON CORP's High Yield stocks
4. Stocks that CAXTON CORP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)